Janssen Research & Development, LLC
Records under this name other than the patents Janssen Research & Development, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Janssen Research & Development, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,537,573 | Combinations Comprising Positive Allosteric Modulators or Orthosteric Agonists of Metabotropic Glutamatergic Receptor Subtype 2 and Their Use conveyed to Janssen Pharmaceutica N.V. In force · High confidence | In force | High confidence | |
| US 10,342,795 | SUBSTITUTED 4,5,6,7-Tetrahydro-PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND 2,3-Dihydro-1H-IMIDAZO[1,2-b]PYRAZOLE DERIVATIVES AS ROS1 INHIBITORS now held by Novalix In force · High confidence | In force | High confidence | |
| US 10,869,844 | Methods For The Treatment Of Depression conveyed to Janssen Pharmaceutica N.V. In force · Low confidence | In force | Low confidence | |
| US 9,949,874 | Therapeutic Agent Delivery Device with Convergent Lumen now held by Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 9,925,088 | Sub-Retinal Tangential Needle Catheter Guide and Introducer now held by Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 12,076,385 | Methods and Compositions for Immune Protection Against Extra-Intestinal Pathogenic E. Coli conveyed to Janssen Pharmaceuticals, Inc. In force · Low confidence | In force | Low confidence | |
| US 11,484,582 | Methods and Compositions for Immune Protection Against Extra-Intestinal Pathogenic E. Coli conveyed to Janssen Pharmaceuticals Inc. - now held by Glaxosmithkliin Biologicals S.A. In force · Low confidence | In force | Low confidence | |
| US 10,583,185 | Methods and Compositions for Immune Protection Against Extra-Intestinal Pathogenic E. Coli conveyed to Janssen Pharmaceuticals Inc. - now held by GlaxoSmithKline Biologicals S.A. In force · High confidence | In force | High confidence | |
| US 10,064,752 | Motorized Suprachoroidal Injection of Therapeutic Agent now held by Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 10,258,502 | Therapeutic Agent Delivery Device now held by Genentech, Inc. In force · High confidence | In force | High confidence |